Spike (B.1.1.7, Alpha Variant) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter)

BPS Bioscience

Spike (B.1.1.7, Alpha Variant) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter)

7

Neutralisation/Blocking

Research Use Only

The Spike (SARS-CoV-2, UK variant) Pseudotyped Lentivirus were produced with SARS-CoV-2 UK Variant Spike (Genbank Accession #QHD43416.1 with UK variant mutations; see below for details) as the envelope glycoproteins instead of the commonly used VSV-G. These pseudovirions contain the firefly luciferase gene driven by a CMV promoter, therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (SARS-CoV-2, UK variant) pseudotyped lentivirus can be used to measure the activity of neutralizing antibody against SARS-CoV-2 UK variant in a Biosafety Level 2 facility.

-80°C

41106621